Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-012841

Director acquired 4,466 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Peyer James Director 2022-06-10 Grant or award +4,466 5,235,954 I
Derivatives
Peyer James Director 2022-06-10 Grant or award · Stock Option (right to buy) +14,550 14,550 I
Loading xslF345X03/doc1.xml…